• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精神药物丁螺环酮、MJ - 13805和匹莫齐特及其共同活性代谢物1 - (2 - 嘧啶基) - 哌嗪在大鼠体内的处置情况。

Disposition of the psychotropic drugs buspirone, MJ-13805 and piribedil, and of their common active metabolite 1-(2-pyrimidinyl)-piperazine in the rat.

作者信息

Caccia S, Fong M H, Guiso G

出版信息

Xenobiotica. 1985 Oct;15(10):835-44. doi: 10.3109/00498258509045035.

DOI:10.3109/00498258509045035
PMID:2866634
Abstract

1-(2-Pyrimidinyl)-piperazine (PmP) is a common metabolite of the structurally related drugs buspirone, MJ-13805 and piribedil. After i.v. injection (25 mumol/kg) to rats, all three parent drugs are rapidly cleared with a t 1/2 (beta) of about 30 min. The metabolite t 1/2 is about four times that of its parent drugs. About 25, 23 and 2% of buspirone, MJ-13805 and piribedil, respectively, reaches the systemic circulation as PmP. The metabolite concentrates in the brain where its A.U.C. is about twice those of buspirone and MJ-13805. Results indicate that PmP formation is a pharmacologically significant process for both buspirone and MJ-13805 but it is probably less important for piribedil.

摘要

1-(2-嘧啶基)-哌嗪(PmP)是结构相关药物丁螺环酮、MJ-13805和吡贝地尔的常见代谢产物。给大鼠静脉注射(25 μmol/kg)后,所有三种母体药物均迅速清除,t 1/2(β)约为30分钟。代谢产物的t 1/2约为其母体药物的四倍。丁螺环酮、MJ-13805和吡贝地尔分别约有25%、23%和2%以PmP的形式进入体循环。该代谢产物在脑中浓缩,其AUC约为丁螺环酮和MJ-13805的两倍。结果表明,PmP的形成对丁螺环酮和MJ-13805而言是一个具有药理学意义的过程,但对吡贝地尔可能不太重要。

相似文献

1
Disposition of the psychotropic drugs buspirone, MJ-13805 and piribedil, and of their common active metabolite 1-(2-pyrimidinyl)-piperazine in the rat.精神药物丁螺环酮、MJ - 13805和匹莫齐特及其共同活性代谢物1 - (2 - 嘧啶基) - 哌嗪在大鼠体内的处置情况。
Xenobiotica. 1985 Oct;15(10):835-44. doi: 10.3109/00498258509045035.
2
1-(2-Pyrimidinyl)-piperazine as active metabolite of buspirone in man and rat.1-(2-嘧啶基)哌嗪作为丁螺环酮在人和大鼠体内的活性代谢物。
Pharmacology. 1986;33(1):46-51. doi: 10.1159/000138199.
3
Disposition and metabolism of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine in the rat.丁螺环酮及其代谢产物1-(2-嘧啶基)-哌嗪在大鼠体内的处置与代谢
Xenobiotica. 1983 Mar;13(3):147-53. doi: 10.3109/00498258309052248.
4
The alpha 2-adrenoceptor antagonist activity of ipsapirone and gepirone is mediated by their common metabolite 1-(2-pyrimidinyl)-piperazine (PmP).伊沙匹隆和吉哌隆的α2-肾上腺素能受体拮抗活性由它们的共同代谢产物1-(2-嘧啶基)-哌嗪(PmP)介导。
Eur J Pharmacol. 1988 Jul 14;151(3):365-71. doi: 10.1016/0014-2999(88)90532-8.
5
Cyp2D6 catalyzes 5-hydroxylation of 1-(2-pyrimidinyl)-piperazine, an active metabolite of several psychoactive drugs, in human liver microsomes.细胞色素P450 2D6(Cyp2D6)在人肝微粒体中催化1-(2-嘧啶基)-哌嗪的5-羟基化反应,1-(2-嘧啶基)-哌嗪是几种精神活性药物的活性代谢产物。
Drug Metab Dispos. 2005 Feb;33(2):203-8. doi: 10.1124/dmd.104.001198. Epub 2004 Oct 26.
6
Behavioral studies with anxiolytic drugs. III. Antipunishment actions of buspirone in the pigeon do not involve benzodiazepine receptor mechanisms.抗焦虑药物的行为学研究。III. 丁螺环酮在鸽子中的抗惩罚作用不涉及苯二氮䓬受体机制。
J Pharmacol Exp Ther. 1986 Sep;238(3):1009-13.
7
In-vivo metabolism of 4-substituted arylpiperazines to pharmacologically active 1-arylpiperazines.4-取代芳基哌嗪在体内代谢为具有药理活性的1-芳基哌嗪。
Boll Chim Farm. 1990 May;129(5):183-9.
8
Effects of buspirone and its metabolite, 1-(2-pyrimidinyl)piperazine, on brain monoamines and their metabolites in rats.
J Pharmacol Exp Ther. 1989 Jan;248(1):50-6.
9
Kinetics, brain uptake, and receptor binding of tandospirone and its metabolite 1-(2-pyrimidinyl)-piperazine.坦度螺酮及其代谢物1-(2-嘧啶基)-哌嗪的动力学、脑摄取及受体结合
J Clin Psychopharmacol. 1992 Oct;12(5):341-5.
10
Lack of interaction between cimetidine and buspirone.西咪替丁与丁螺环酮之间无相互作用。
Pharmacotherapy. 1987;7(3):72-9. doi: 10.1002/j.1875-9114.1987.tb03521.x.

引用本文的文献

1
Clinical pharmacokinetics of oral buspirone in patients with impaired renal function.肾功能受损患者口服丁螺环酮的临床药代动力学
Clin Pharmacokinet. 1988 Mar;14(3):171-7. doi: 10.2165/00003088-198814030-00005.
2
Buspirone. A preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic.丁螺环酮。作为一种抗焦虑药的药理特性及治疗效果的初步综述。
Drugs. 1986 Aug;32(2):114-29. doi: 10.2165/00003495-198632020-00002.
3
Mode of action of tiaspirone on the central cholinergic system.替螺酮对中枢胆碱能系统的作用机制。
Naunyn Schmiedebergs Arch Pharmacol. 1989 Sep;340(3):259-64. doi: 10.1007/BF00168507.
4
A metabolite of buspirone increases locus coeruleus activity via alpha 2-receptor blockade.丁螺环酮的一种代谢产物通过α2受体阻断作用增加蓝斑核活性。
J Neural Transm. 1989;76(2):91-8. doi: 10.1007/BF01578749.
5
Kinetics of piribedil and effects on dopamine metabolism: hepatic biotransformation is not a determinant of its dopaminergic action in rats.
Psychopharmacology (Berl). 1991;105(4):541-5. doi: 10.1007/BF02244377.
6
1-(2-pyrimidinyl)-piperazine may alter the effects of the 5-HT1A agonist in the learned helplessness paradigm in rats.1-(2-嘧啶基)-哌嗪可能会改变5-羟色胺1A受体激动剂在大鼠习得性无助范式中的作用。
Psychopharmacology (Berl). 1991;104(2):275-8. doi: 10.1007/BF02244191.